Skip to content
Dose Brief
Menu
No. 9 on the board · Grade BEditorial review

Henry Meds review

A flat-fee compounded pioneer — simple model, but its price has drifted to the higher end of our board.

Visit Henry Meds Editorial review — no commercial relationship.
Semaglutide
$249/mo
Tirzepatide
$349/mo
Coverage
Multi-state
Brand-name
Compounded only
On the trackerRisingprice risingFlat-fee pioneer, but its line has drifted to the higher end of the tracker.

The scorecard

Henry Meds scored on our six Brief Score factors. See the methodology.

Price Stability85/100
Supply Reliability84/100
Transparency85/100
Access Breadth82/100
Clinical Oversight84/100
Track Record85/100

What we like

  • Simple flat-fee model
  • Well-established brand
  • Both molecules

The caveats

  • Higher pricing than many newer entrants
  • Compounded only

The brief

Best for: Readers who want a simple, well-known flat-fee program and don't mind paying up for it. A flat-fee compounded pioneer — simple model, but its price has drifted to the higher end of our board.

Ranked #9 of 9 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 8 other providers we've reviewed, in our overall ranking order.

Pricing, states and verification reflect Henry Meds's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on Henry Meds's site. Not medical advice; see our disclosure.

← Back to all rankings